1) peritoneal dialysis/nursing
腹膜透析/护理
2) peritoneal dialysis
腹膜透析
1.
Countermeasures for peritoneal dialysis retubation;
腹膜透析二次置管的原因及对策
2.
Diagnostic value of CT peritoneography for non-infectious complications of peritoneal dialysis;
腹腔CT影像学检查在腹膜透析相关非感染性腹腔并发症中的诊断价值
3.
Effects of low-protein diet plus α-keto acid on micro-inflammation and the relationship between micro-inflammation and nutritional status in patients performing continuous ambulatory peritoneal dialysis:a randomized controlled trial;
复方α-酮酸配伍低蛋白饮食对长期腹膜透析患者微炎症的影响及其与营养状态关系的随机对照研究
3) Peritoneal dialysate
腹膜透析液
1.
Peritoneal dialysate induces connective tissue growth factor expression in rat peritoneal mesotbelial cells;
腹膜透析液诱导结缔组织生长因子在大鼠腹膜间皮细胞表达
2.
Effects of high-glucose peritoneal dialysate on viability and nitric oxide production of murine peritoneal macrophages;
高糖腹膜透析液对小鼠腹腔巨噬细胞活力和NO产生的影响
3.
Methods: Peritoneal macrophages of mice were cultured in culture medium (control), peritoneal dialysate (PD), drugs contained PD containing Angelica, Salvia and Ligustrazine combined (PD ASL) or separated (PD A, PD S, PD L) with concentration of 2μg/ml, 10μg/ml and 100μg/ml, separately for 24 hrs.
方法 :(1)将MC置于含当归、丹参和川芎嗪的腹膜透析液 (CDS)的培养液中培养 2 4h ,测定 3个中药组、CDS组和对照组MC的一氧化氮 (NO)含量和对四甲基偶氮唑盐 (MTT)还原能力。
4) peritoneal dialysis solution
腹膜透析液
1.
Methods HPMC cultured in vitro were divided into 5 groups,RPMI 1640 culture medium as control,peritoneal dialysis solution(PDS) containing 2.
方法:体外培养人腹膜间皮细胞,分对照组,腹膜透析液(PDS)组及葛根素1、2、3组(葛根素终浓度依次为50、100、200μg。
6) peritoneal dialysis clamp
腹膜透析夹
补充资料：腹膜透析
腹膜透析
〖HT5”SS〗peritoneal dialysis
为肾功能衰竭所引起尿毒症的一种治疗方法。利用腹膜作为透析膜，把含有一定成分和渗透压的透析液输入腹腔，通过腹膜与体内物质互相扩散，使体内蓄积的代谢废物从透析液排出，而透析液中的某些物质亦可向体内移动。如此不断地更换透析液，有效地排出体内积聚的代谢产物，调节水和电解质平衡，纠正酸中毒。对改善血液和体液的病理生理变化起到一定的肾功能作用。腹膜透析也可用于治疗某些中毒，如巴比妥类药物中毒。有间歇性腹膜透析(IPO）及不卧床持续性腹膜透析(APD）等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条